Skip to content

Clinical trials

Phase 1/2 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1/2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20061
20092
20101
20121
20171
20184
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
Vir Biotechnology, Inc.2
ANRS, Emerging Infectious Diseases1
Arrowhead Pharmaceuticals1
Barinthus Biotherapeutics1
Biotest Pharmaceuticals Corporation1
Columbia University1
Cytheris SA1
Foundation for Liver Research1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B19
Hepatitis B, Chronic7
Bronchiolitis Obliterans Syndrome2
HIV Infections2
Hepatitis2
Hepatitis C2
Liver Diseases2
Liver Failure2
Carcinoma, Hepatocellular1
Hepatic Insufficiency1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.